↓ Skip to main content

Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats

Overview of attention for article published in Frontiers in Pharmacology, July 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Published in
Frontiers in Pharmacology, July 2021
DOI 10.3389/fphar.2021.708019
Pubmed ID
Authors

Rahimah Hassan, Sasidharan Sreenivasan, Christian P. Müller, Zurina Hassan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 12%
Researcher 3 12%
Student > Doctoral Student 2 8%
Other 2 8%
Student > Ph. D. Student 1 4%
Other 1 4%
Unknown 13 52%
Readers by discipline Count As %
Unspecified 3 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 12%
Medicine and Dentistry 3 12%
Materials Science 1 4%
Nursing and Health Professions 1 4%
Other 0 0%
Unknown 14 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 August 2021.
All research outputs
#15,177,363
of 23,342,092 outputs
Outputs from Frontiers in Pharmacology
#5,475
of 16,802 outputs
Outputs of similar age
#236,998
of 437,479 outputs
Outputs of similar age from Frontiers in Pharmacology
#250
of 922 outputs
Altmetric has tracked 23,342,092 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,802 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,479 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 922 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.